Activities in the field of biotechnology and bioactive substances have increased significantly around the world.
Researchers have increasingly focused on research in this area, as their findings are thought to play an important role in combating current and future health problems. In addition, scientists believe that some of the world's energy problems can be solved with biotechnology. One example of the benefits of biotechnology and bioactive substances are fish peptides that can potentially lower blood pressure in humans. The reduction of hypertension is a matter of great competition, as the cost to the health system of cardiovascular disease is significant, but hypertension is precisely one of the risk factors for these diseases (see leaflet on this topic). here).
For the past two years, Prokaria has been collaborating with a foreign chemical company in the field of biotechnology and bioactive substances. Now this company has bought from Matís important enzymes that it intends to use in its energy research. The sale value of this contract is no more no less than 60,000 euros!
Not bad when money is needed in the Icelandic economy!
It is also interesting to note that Matís-Prokaria has now set up a sales unit for enzymes and other bioactive substances and more information can be found on the Prokazyme website, www.prokazyme.com.
Matís-Prokaria hopes to sell the above products successfully through this new sales system.
For further information, contact Ragnar Jóhannsson, ragnar.johannsson@matis.is, and by phone 422-5000.